EPLAW PATENT BLOG

UK – Adaptive Spectrum and Signal Alignment v British Telecommunications

Posted: December 16th, 2013

Adaptive Spectrum and Signal Alignment Inc. v British Telecommunications PLC Patents Court, London, UK, 3 December 2013, [2013] EWHC 3768 (Pat) Birss J In his judgment, Mr Justice Birss upheld the validity of two patents (“EP’495” and “EP’790”), rejecting BT’s novelty and obviousness attacks.  He found EP’790 to be infringed by one of BT’s systems.  […]

READ MORE

UK – Mylan v. Yeda

Posted: August 5th, 2013

Generics [UK] Limited (trading as Mylan) v Yeda Research and Development Co. Ltd & Anor [2013] EWCA Civ 925, 29 July 2013, Court of AppealThis was an appeal by Mylan against the first instance decision by Arnold J which was noted here.  In this appeal Mylan contended that Arnold J had erred in not holding […]

READ MORE

UK – Sudarshan v. Clariant

Posted: August 5th, 2013

Sudarshan Chemical Industries Ltd -v- Clariant Produkte (Deutschland) GmbH, Court of Appeal (Civil Division), Moore-Bick LJ, Kitchin LJ and Floyd LJ, London, UK, 30 July 2013, Case No.  [2013] EWCA Civ 919 In a judgment handed down on 30 July 2013, the English Court of Appeal has dismissed an appeal brought by Clariant against a […]

READ MORE

UK – Samsung v Apple / Samsung UMTS patents held invalid

Posted: March 18th, 2013

In the latest of the Samsung v Apple battles in the ongoing war between the two technology giants, the UK High Court has revoked three of Samsung’s UMTS (Universal Mobile Telecommunications System) patents. The first judgment dealt with EP 726 and 675, the first relating to turbo codes and the second to channel coding and […]

READ MORE

UK – Glenmark v. GSK (Malarone)

Posted: February 22nd, 2013

Glenmark Generics (Europe) Limited, Generics (UK) Limited (t/a Mylan) v. The Wellcome Foundation Limited, Glaxo Group Limited, High Court of Justice, Chancery Division, Patents Court, London, UK, 7 February 2013, [2013] EWHC 148 (Pat) The Patents Court held that GSK’s patent for an anti-malarial drug was invalid. Glenmark and Mylan applied to revoke GSK’s patent […]

READ MORE

UK – Environmental Recycling Technologies v. Upcycle Holdings

Posted: February 21st, 2013

Environmental Recycling Technologies plc v. Upcycle Holdings Limited, Patents County Court, London, UK, 5 February 2013, [2013] EWPCC 4 The Patents County Court held that Upcycle’s patent relating to a process for moulding plastic articles was valid in its amended form. Environmental Recycling Technologies (ERT) applied to revoked Upcycle’s patent, GB 2 2460 838, relating […]

READ MORE

UK – Omnipharm Limited v Merial

Posted: January 28th, 2013

Omnipharm Limited v Merial, Court of Appeal (Civil Division), London, UK, 23 January 2013, Case No [2013] EWCA Civ 2 This was an appeal against the judgment of Floyd J, dated 21 December 2011, following a trial of an action brought by Omnipharm to revoke two of Merial’s patents, EP (UK) 0 881 881 (the […]

READ MORE

UK – Novartis AG v Generics (UK) Limited (trading as Mylan)

Posted: January 14th, 2013

Novartis AG v Generics (UK) Limited, Court of Appeal (Civil Division), London, UK, 12 December 2012Case No. A3/2011/2970 In this decision, the UK Court of Appeal confirmed that obviousness must be assessed by reference to the invention as described and claimed by a patentee.  In order to undertake that assessment, all the circumstances including, where […]

READ MORE

UK – Microsoft v. Motorola

Posted: January 8th, 2013

Microsoft Corporation and others -v- Motorola Mobility LLC and another, Patents Court, High Court of Justice, London, The Hon Mr Justice Arnold, 21 December 2012, [2012] EWHC 3677 (Pat) This case concerned the validity of Motorola’s European Patent (UK) No. 0 847 654, relating to the synchronisation of message information across multiple mobile devices, and […]

READ MORE